- Injective (INJ) stock rose 5.1% after breaking above key technical resistance.
- Strong volume supports a potential move towards $5.30.
- Analysts highlight improving momentum despite macro risks.
Injective is posting one of the strongest short-term bids among the major altcoins today.
While much of the cryptocurrency market remained weak, the INJ rose more than 5% over the past 24 hours, supported by a decisive technical breakout and a sharp increase in trading activity.
This move shifted focus to the next major resistance level at $5.30.
Meanwhile, improving on-chain metrics and renewed optimism among market analysts have fueled growing interest in the token.
Technical breakout puts $5.30 in focus
At press time, INJ is trading at around $5.02 after rising 5.1% over the past 24 hours.
The recent rally was largely driven by a break above the 30-day simple moving average near $4.85.
Buyers also pushed the token through the 50% Fibonacci retracement level near $5.06, a level that capped previous recovery attempts.
The boom also emerged because it happened at a time Bitcoin It was slightly weaker over the same period, suggesting that the recent advance was primarily driven by Injective’s technical setup rather than broader market strength.
Unlike many short-term price rallies, this breakout was accompanied by stronger participation from traders.
Daily trading volume rose more than 26% to nearly $86.9 million, suggesting the move was fueled by new buying interest rather than weak liquidity.
The next level that is attracting attention now is the 38.2% Fibonacci resistance level near $5.30.
Staying above the $4.85 breakout zone would keep this target in focus, while missing this level could expose the symbol to test another support near $4.50.
On-chain activity continues to support the network
The recent price action also comes alongside several encouraging developments within the Injective ecosystem.
The network has processed over $34 billion in derivatives trading volume, highlighting the ongoing activity across its decentralized financial infrastructure.
Meanwhile, Injective has strengthened the stablecoin ecosystem by supporting native USDC, making it easier for users and developers to access cross-chain liquidity.
Another closely watched metric is the community buyback mechanism.
More than 7.1 million Indonesian eng have now been permanently removed from circulation through the programme, reinforcing the network’s long-term deflationary model.
A recent CoinGecko report puts Injective’s growth into perspective.
Top 10 L1 by protocol revenue, $34B in derivatives volume, native USDC, $7.1M+ $eng Burn through community buyback.$eng It continues to prove its strength through real onchain activity. @injective pic.twitter.com/Fe39MnS5Hm
– The Lost Cat (@0x_Eligible) July 14, 2026
Protocol revenues also remained among the strongest across tier-1 blockchain networks, reflecting sustained activity rather than growth driven solely by speculation.
Although there are no major partnership announcements or protocol upgrades directly tied to the recent price increase, these on-chain metrics continue to provide additional context to the token’s recent resilience.
Analysts point to improved market structure
Market participants have also been monitoring several technical assessments published over the past few days.
Veteran financial trader Matthew Dixon He said the broader cryptocurrency market could still form a significant lower level later in the year, but he identified Injective as one of the stronger-looking altcoins.
According to Dixon, INJ established an important bottom between $2.60 and $2.80 before advancing towards the $6.80 to $7.00 area in what he described as a potential five-wave structure.
More importantly, the subsequent correction failed to create new lows and remained above key Fibonacci retracement levels, a pattern he considers to be healthier than that seen in many competing altcoins.
Dixon highlighted several important support levels that traders should monitor, including $4.57, $4.32, and $4.14. He also noted that the relative strength index, or RSI, was hovering near 53, indicating that momentum was rebuilding rather than weakening.
Dixon added that if Bitcoin experiences another broad market decline of around 20%, Injective could reconsider $3.75, as $3.40 represents a more extreme bearish scenario during a broad market sell-off.
A separate chart shared by FurkanConsensus also pointed to long-term structure optimization. The analyst identified a recurring area of liquidity and accumulation on the weekly chart that frequently preceded major price movements.
Historical examples highlighted by the Vorcan Consensus include a rally of around 300% after the area was retested in March 2023 and another advance of around 160% after around 70 days of accumulation between March and April 2026.
FurkanConsensus also noted that not every visit to the level immediately resulted in gains, citing November 2022, when the token briefly touched the area before falling further.
$eng Scheme 1W
I’m not sure, but it looks like the lines are on $eng The chart has been running well. I also discovered a new level, which I marked with the green line because it seems that the price has constantly visited this area for liquidity and accumulation.
now… pic.twitter.com/VM3o26thZK
– Furkan Consensus 🦇🔊🍉 (@FurkanConsensus) July 13, 2026
The short-term outlook remains tied to key support
Despite the recent breakout, the next few trading sessions will likely determine whether the move develops into a broader recovery.
Maintaining support above $4.85 would leave the door open for another attempt at $5.30, especially if trading volume remains high.
A successful move above that resistance could boost the upward momentum further.
However, traders should also closely monitor broader market conditions.
Reaction to the latest US inflation data and Bitcoin’s ability to maintain its support levels may continue to influence sentiment across the altcoin market.
